NEA Secondary — 2024 Investments

2 investments dated 2024 · listed companies and verified rows first · show all

Brenig Therapeutics, Inc.Jul 2024SEC filingmedium confidence

BiotechDover, US

Iain Dukes(Executive Officer, Director)Nikolay Savchuk(Executive Officer, Director)

BoardKeno Gutierrez(Director)Michele Cucullu(Director)

Board seatEdward Mathers· per SEC Form D · $65M raise · filed Jul 2024

Co-investorsNew Enterprise Associates (NEA)

Cardurion Pharmaceuticals, Inc.Jul 2024SEC filingmedium confidence

BiotechBurlington, US

Michael Mendelsohn(Executive Officer, Director)

BoardEvan Rachlin(Director)Peter Lawrence(Executive Officer, Director)Adam Koppel(Director)inNicholas Downing(Director)

Board seatEdward Mathers· per SEC Form D · $260.4M raise · filed Jul 2024

Co-investorsBain Capital Life Sciences Bain Capital Polaris Partners Third Rock Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.